Freiburg, Germany: November 13, 2024 - StageBio, a leading provider of GLP-compliant histology, pathology, image analysis and archiving services for both preclinical and clinical research, is excited to announce their European division will be relocating. As of November 25, 2024, StageBio’s new facility, located in Germany, will be located at TPL Path Labs GmbH, [a StageBio company], Tullastrasse No 85-87 B, 79108 Freiburg, Germany.

StageBio’s state of the art facility includes advanced resources and an expanded workspace, allowing our team of scientific experts of over 125+ to best serve our clients. StageBio’s Germany location is suited to provide support for a full suite of preclinical and clinical projects, from study protocol development through necropsy, histology, pathology, image analysis and archiving.

“This new location will allow us to better serve the growing and evolving needs of our clients. We look forward to this exciting development for our European division and beyond.” - Ayse Bal, Managing Director.

For more information about our European site, please reach out to Managing Director Ayse Bal, abal@stagebio.com, or contact us here.

About StageBio

StageBio is a leading provider of GLP-compliant necropsy, histology, pathology and specimen archiving services for the biopharmaceutical, medical device, academic, government and contract research industries. The company operates three GLP laboratories as well as two GLP specimen archiving facilities in the U.S. and Europe, with substantial continued investment in facility and technology infrastructure to meet the growing demand for high-quality histopathology services globally. StageBio has a team of 25 board-certified veterinary pathologists and more than 100 scientific personnel on staff supporting our unified commitment to quality, scientific integrity and client satisfaction. Learn more at www.stagebio.com.